v3.26.1
SCHEDULE OF SEGMENT INFORMATION (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting [Line Items]        
Revenue $ 988,542 $ 1,098,962 $ 1,969,320 $ 2,167,265
Cost of Sales     (1,610,333) (1,990,898)
Gross Profit     358,987 176,367
Operating Expenses     (4,804,802) (6,863,946)
Operating Loss (1,793,375) (2,755,461) (4,445,815) (6,687,579)
Other Expense $ (4,027,566) $ (6,085,681) (6,630,409) (11,615,507)
Net Loss Before Income Tax     (11,076,224) (18,303,086)
Real Estate Segment[Member]        
Segment Reporting [Line Items]        
Revenue     1,450,972 1,433,847
Cost of Sales     (1,276,645) (1,254,761)
Gross Profit     174,327 179,086
Operating Expenses     (1,156,864) (1,378,493)
Operating Loss     (982,537) (1,199,407)
Other Expense     1,340 (458,681)
Net Loss Before Income Tax     (981,197) (1,658,088)
Digital Transformation Technology [Member]        
Segment Reporting [Line Items]        
Revenue    
Cost of Sales    
Gross Profit    
Operating Expenses     (73,352) (323,406)
Operating Loss     (73,352) (323,406)
Other Expense     (101,266) (881,753)
Net Loss Before Income Tax     (174,618) (1,205,159)
Biohealth Business [Member]        
Segment Reporting [Line Items]        
Revenue    
Cost of Sales    
Gross Profit    
Operating Expenses     (398,938) (402,049)
Operating Loss     (398,938) (402,049)
Other Expense     296,207 (2,875,116)
Net Loss Before Income Tax     (102,732) (3,277,165)
Other [Member]        
Segment Reporting [Line Items]        
Revenue     518,348 733,418
Cost of Sales     (333,688) (736,137)
Gross Profit     184,660 (2,719)
Operating Expenses     (3,175,648) (4,759,998)
Operating Loss     (2,990,988) (4,762,717)
Other Expense     (6,826,690) (7,399,957)
Net Loss Before Income Tax     $ (9,817,678) $ (12,162,674)